Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−0.0875EUR
−2.68 MEUR
60.96 KEUR
34.42 M
About INTELLIPHARMACEUTICS INTL INC
Sector
CEO
Isa Odidi
Headquarters
Toronto
Website
Founded
1998
FIGI
BBG002J5JQP8
Intellipharmaceutics International, Inc. is a pharmaceutical company, which engages in the research, development, and manufacture of novel and generic controlled-release and targeted-release oral solid dosage drugs. Its patented Hypermatrix technology is a controlled-release drug delivery platform that can be applied to the development of pharmaceuticals in the areas of neurology, cardiovascular, gastrointestinal tract, diabetes, and pain. The company was founded by Isa Odidi and Amina Odidi on October 22, 2009 and is headquartered in Toronto, Canada.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
Depending on the exchange, the stock ticker may vary. For instance, on FWB exchange INTELLIPHARMACEUTICS INTL stocks are traded under the ticker I4AA.
I4AA reached its all-time high on Sep 26, 2018 with the price of 2.7300 EUR, and its all-time low was 0.0140 EUR and was reached on Jul 18, 2022. View more price dynamics on I4AA chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
Yes, you can track INTELLIPHARMACEUTICS INTL financials in yearly and quarterly reports right on TradingView.
INTELLIPHARMACEUTICS INTL is going to release the next earnings report on Jul 17, 2024. Keep track of upcoming events with our Earnings Calendar.
I4AA net income for the last quarter is −1.72 M EUR, while the quarter before that showed −50.61 K EUR of net income which accounts for −3.30 K% change. Track more INTELLIPHARMACEUTICS INTL financial stats to get the full picture.
No, I4AA doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. INTELLIPHARMACEUTICS INTL EBITDA is −2.14 M EUR, and current EBITDA margin is −4.00 K%. See more stats in INTELLIPHARMACEUTICS INTL financial statements.
Like other stocks, I4AA shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade INTELLIPHARMACEUTICS INTL stock right from TradingView charts — choose your broker and connect to your account.